Phospho-PBK/TOPK (Thr9) Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Phospho-PBK/TOPK (Thr9) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityPhospho-PBK/TOPK (Thr9)
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman
Isotypen/a
Formatunconjugated
Size0.05 mL, 0.2 mL
Concentrationn/a
ApplicationsWestern Blot (WB), ELISA (EIA)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThis Phospho-PBK/TOPK (Thr9) antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 2-35 amino acids from the human Phospho-PBK/TOPK. Phosphorylates MAP kinase p38. Seems to be active only in mitosis. May also play a role in the activation of lymphoid cells. When phosphorylated, forms a complex with TP53, leading to TP53 destabilization and attenuation of G2/M checkpoint during doxorubicin-induced DNA damage.
Immunogenn/a
Other Names[Lymphokine-activated killer T-cell-originated protein kinase; 2.7.12.2; Cancer/testis antigen 84; CT84; MAPKK-like protein kinase; Nori-3; PDZ-binding kinase; Spermatogenesis-related protein kinase; SPK; T-LAK cell-originated protein kinase; PBK; TOPK]
Gene, Accession #[PBK], Gene ID: 55872, NCBI: NP_001265874.1, UniProt: Q96KB5
Catalog #MBS9231103
Price$165, $370
Order / More InfoPhospho-PBK/TOPK (Thr9) Antibody from MYBIOSOURCE INC.
Product Specific ReferencesAbe Y.,et al.J. Biol. Chem. 275:21525-21531 (2000). Gaudet S.,et al.Proc. Natl. Acad. Sci. U.S.A. 97:5167-5172 (2000). Zhao S.,et al.Int. J. Biochem. Cell Biol. 33:631-636 (2001). Ota T.,et al.Nat. Genet. 36:40-45 (2004). Nusbaum C.,et al.Nature 439:331-335 (2006).
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.